Publications

Human monoclonal antibodies inhibit invasion of transgenic Plasmodium knowlesi expressing Plasmodium vivax Duffy binding protein.

Watson, QD; Carias, LL; Malachin, A; Redinger, KR; Bosch, J; Bardelli, M; Baldor, L; Feufack-Donfack, LB; Popovici, J; MOON, RW; Draper, SJ; Zimmerman, PA; King, CL;

2023

Malaria journal, (2023).22 1 10.1186/s12936-023-04766-1.

What factors are associated with paediatric admissions and their outcomes in a rural hospital in northern Sierra Leone? Insights from a pilot observational study.

AFOLABI, MO; Ayieko, P; Njie, Y; Kowuor, D; Adetola, HH; Kamara, B; Jalloh, AB; Sesay, F; Swaray, E; Odeny, L; Pearce, RM; Samai, MH; Deen, GF; Koedoyoma, S; Sesay, IG; Ishola, D; Leigh, B; WATSON-JONES, D; GREENWOOD, B;

2023

BMJ Public Health, (2023).1 1 10.1136/bmjph-2023-000545.

Acceptance of and Adherence to a Four-Dose RTS,S/AS01 Schedule: Findings from a Longitudinal Qualitative Evaluation Study for the Malaria Vaccine Implementation Programme.

Price, J; Gurley, N; Gyapong, M; Ansah, EK; Awusabo-Asare, K; Gyasi, SF; Nkhoma, P; Nyondo-Mipando, AL; Okello, G; WEBSTER, J; DESMOND, N; Hill, J; Gordon, WS;

2023

Vaccines, (2023).11 12 10.3390/vaccines11121801.

PA-311 Vitamin D status and the risk of malaria among under-five children in Africa.

NJOROGE, M;

2023

Abstracts of Poster and e-Poster Presentations (2023). 10.1136/bmjgh-2023-edc.157.

Building the vector in: construction practices and the invasion and persistence of Anopheles stephensi in Jigjiga, Ethiopia.

Yared, S; Gebresilassie, A; Aklilu, E; Abdulahi, E; Kirstein, OD; Gonzalez-Olvera, G; Che-Mendoza, A; Bibiano-Marin, W; Waymire, E; LINES, J; Lenhart, A; Kitron, U; Carter, T; Manrique-Saide, P; Vazquez-Prokopec, GM;

2023

The Lancet. Planetary health, (2023).7 12 10.1016/s2542-5196(23)00250-4.

Targeted malaria elimination interventions reduce Plasmodium falciparum infections up to 3 kilometers away.

Benjamin-Chung, J; Li, H; Nguyen, A; Heitmann, GB; Bennett, A; Ntuku, H; Prach, LM; Tambo, M; Wu, L; Drakeley, C; GOSLING, R; Mumbengegwi, D; KLEINSCHMIDT, I; Smith, JL; Hubbard, A; Van der Laan, M; Hsiang, MS;

2023

medRxiv (2023). 10.1101/2023.09.19.23295806.

Master statistical analysis plan: attractive targeted sugar bait phase III trials in Kenya, Mali, and Zambia.

Yukich, J; Eisele, TP; TerKuile, F; Ashton, R; Staedke, S; Harris, AF; Johnson, PC D; SARRASSAT, S; Lesosky, M; BRADLEY, J; KLEINSCHMIDT, I; Littrell, M; Attractive Targeted Sugar Bait Phase III Trial Gro,;

2023

Trials, (2023).24 1 10.1186/s13063-023-07762-7.

Treatment Failure in a UK Malaria Patient Harboring Genetically Variant Plasmodium falciparum From Uganda With Reduced In Vitro Susceptibility to Artemisinin and Lumefantrine.

VAN SCHALKWYK, DA; PRATT, S; NOLDER, D; STEWART, LB; Liddy, H; MUWANGUZI-KARUGABA, J; BESHIR, KB; Britten, D; Victory, E; Rogers, C; Millard, J; Brown, M; Nabarro, LE; Taylor, A; Young, BC; Chiodini, PL; SUTHERLAND, CJ;

2023

Clinical Infectious Diseases, (2023).78 2 10.1093/cid/ciad724.

Identification of the PfK13 mutations R561H and P441L in the Democratic Republic of Congo.

Mesia Kahunu, G; Wellmann Thomsen, S; Wellmann Thomsen, L; Muhindo Mavoko, H; Mitashi Mulopo, P; Filtenborg Hocke, E; Mandoko Nkoli, P; Baraka, V; Minja, DT R; MOUSA, A; ROPER, C; Mbongi Moke, D; Mumba Ngoyi, D; Mukomena Sompwe, E; Muyembe Tanfum, JJ; Hansson, H; Alifrangis, M;

2023

International Journal of Infectious Diseases, (2023).139, 10.1016/j.ijid.2023.11.026.

Optimisation-based modelling for explainable lead discovery in malaria.

Li, Y; Cardoso-Silva, J; KELLY, JM; DELVES, MJ; FURNHAM, N; Papageorgiou, LG; Tsoka, S;

2023

Artificial intelligence in medicine, (2023).147, 10.1016/j.artmed.2023.102700.